25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIOR (Biora Therapeutics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biora Therapeutics Inc together

I guess you are interested in Biora Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Biora Therapeutics Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Biora Therapeutics Inc’s Price Targets

I'm going to help you getting a better view of Biora Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biora Therapeutics Inc

I send you an email if I find something interesting about Biora Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Biora Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Biora Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
33.3%

What is your share worth?

Current worth
$-6.43
Expected worth in 1 year
$21.44
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$27.87
Return On Investment
12,667.3%

For what price can you sell your share?

Current Price per Share
$0.22
Expected price per share
$0.22 - $0.22
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biora Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.22
Intrinsic Value Per Share
$-71.64 - $379.14
Total Value Per Share
$-78.07 - $372.71

2.2. Growth of Biora Therapeutics Inc (5 min.)




Is Biora Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$101.4m-$102.2m$866k0.9%

How much money is Biora Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$124.1m-$48.8m-$75.2m-60.7%
Net Profit Margin-3,102,875.0%-16,009.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Biora Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biora Therapeutics Inc?

Welcome investor! Biora Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Biora Therapeutics Inc.

First you should know what it really means to hold a share of Biora Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Biora Therapeutics Inc is $0.22. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biora Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biora Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-6.43. Based on the TTM, the Book Value Change Per Share is $6.97 per quarter. Based on the YOY, the Book Value Change Per Share is $5.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biora Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-7.87-3,576.7%-7.87-3,576.7%-6.40-2,907.0%-32.44-14,744.8%-31.79-14,449.9%
Usd Book Value Change Per Share6.973,166.8%6.973,166.8%5.392,450.8%0.35158.5%-1.07-487.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.2090.5%0.33150.8%
Usd Total Gains Per Share6.973,166.8%6.973,166.8%5.392,450.8%0.55249.0%-0.74-336.4%
Usd Price Per Share1.35-1.35-0.13-1.78-1.48-
Price to Earnings Ratio-0.17--0.17--0.02--0.07--0.06-
Price-to-Total Gains Ratio0.19-0.19-0.02--0.10--0.10-
Price to Book Ratio-0.21--0.21--0.01--0.11--0.09-
Price-to-Total Gains Ratio0.19-0.19-0.02--0.10--0.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.22
Number of shares4545
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.20
Usd Book Value Change Per Share6.970.35
Usd Total Gains Per Share6.970.55
Gains per Quarter (4545 shares)31,665.072,489.70
Gains per Year (4545 shares)126,660.309,958.79
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10126660126650361863419949
2025332125331072361268219908
30379981379970108531902329867
40506641506630144712536439826
50633301633290180893170549785
60759962759950217073804659744
70886622886610253244438769703
8010132821013270289425072879662
9011399431139930325605706989621
10012666031266590361786341099580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%3.03.00.050.0%3.03.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%2.00.04.033.3%2.00.04.033.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%3.03.00.050.0%3.03.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biora Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.9676.9670%5.392+29%0.349+1897%-1.072+115%
Book Value Per Share---6.430-6.4300%-13.397+108%-16.164+151%-14.832+131%
Current Ratio--0.3030.3030%1.636-81%1.204-75%1.193-75%
Debt To Asset Ratio--4.2494.2490%2.911+46%2.492+71%2.296+85%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%0.199-100%0.332-100%
Enterprise Value---96131049.050-96131049.0500%-124318165.876+29%-115439308.732+20%-115439308.732+20%
Eps---7.869-7.8690%-6.395-19%-32.438+312%-31.790+304%
Ev To Ebitda Ratio--0.8430.8430%3.328-75%1.380-39%1.380-39%
Ev To Sales Ratio---24032.762-24032.7620%-407.601-98%-6129.819-74%-6129.819-74%
Free Cash Flow Per Share---3.081-3.0810%-8.541+177%-22.174+620%-21.057+583%
Free Cash Flow To Equity Per Share---1.130-1.1300%-7.585+571%-0.879-22%-3.783+235%
Gross Profit Margin--1.0001.0000%1.0000%1.140-12%1.181-15%
Intrinsic Value_10Y_max--379.144--------
Intrinsic Value_10Y_min---71.635--------
Intrinsic Value_1Y_max---4.590--------
Intrinsic Value_1Y_min---18.582--------
Intrinsic Value_3Y_max--18.661--------
Intrinsic Value_3Y_min---46.285--------
Intrinsic Value_5Y_max--81.039--------
Intrinsic Value_5Y_min---63.314--------
Market Cap994994.000-2040%21293950.95021293950.9500%1007834.124+2013%11153953.015+91%9294960.846+129%
Net Profit Margin---31028.750-31028.7500%-160.098-99%-6267.126-80%-5222.773-83%
Operating Margin---28652.250-28652.2500%-125.443-100%-5782.883-80%-4819.219-83%
Operating Ratio--16925.50016925.5000%206.534+8095%3446.857+391%2872.696+489%
Pb Ratio-0.034+84%-0.210-0.2100%-0.010-95%-0.111-47%-0.093-56%
Pe Ratio-0.028+84%-0.172-0.1720%-0.021-88%-0.071-59%-0.059-66%
Price Per Share0.220-514%1.3501.3500%0.132+923%1.776-24%1.480-9%
Price To Free Cash Flow Ratio-0.071+84%-0.438-0.4380%-0.015-96%-0.130-70%-0.108-75%
Price To Total Gains Ratio0.032-514%0.1940.1940%0.024+691%-0.098+150%-0.098+150%
Quick Ratio--0.2550.2550%1.344-81%0.992-74%1.035-75%
Return On Assets---3.976-3.9760%-0.912-77%-1.846-54%-1.723-57%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share--6.9676.9670%5.392+29%0.548+1172%-0.740+111%
Usd Book Value---101421000.000-101421000.0000%-102287000.000+1%-95910400.000-5%-86086666.667-15%
Usd Book Value Change Per Share--6.9676.9670%5.392+29%0.349+1897%-1.072+115%
Usd Book Value Per Share---6.430-6.4300%-13.397+108%-16.164+151%-14.832+131%
Usd Dividend Per Share----0%-0%0.199-100%0.332-100%
Usd Enterprise Value---96131049.050-96131049.0500%-124318165.876+29%-115439308.732+20%-115439308.732+20%
Usd Eps---7.869-7.8690%-6.395-19%-32.438+312%-31.790+304%
Usd Free Cash Flow---48602000.000-48602000.0000%-65209000.000+34%-112537800.000+132%-105441166.667+117%
Usd Free Cash Flow Per Share---3.081-3.0810%-8.541+177%-22.174+620%-21.057+583%
Usd Free Cash Flow To Equity Per Share---1.130-1.1300%-7.585+571%-0.879-22%-3.783+235%
Usd Market Cap994994.000-2040%21293950.95021293950.9500%1007834.124+2013%11153953.015+91%9294960.846+129%
Usd Price Per Share0.220-514%1.3501.3500%0.132+923%1.776-24%1.480-9%
Usd Profit---124115000.000-124115000.0000%-48830000.000-61%-138406200.000+12%-136856166.667+10%
Usd Revenue--4000.0004000.0000%305000.000-99%43970800.000-100%57971333.333-100%
Usd Total Gains Per Share--6.9676.9670%5.392+29%0.548+1172%-0.740+111%
 EOD+1 -7MRQTTM+0 -0YOY+21 -145Y+21 -1710Y+23 -15

3.3 Fundamental Score

Let's check the fundamental score of Biora Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.028
Price to Book Ratio (EOD)Between0-1-0.034
Net Profit Margin (MRQ)Greater than0-31,028.750
Operating Margin (MRQ)Greater than0-28,652.250
Quick Ratio (MRQ)Greater than10.255
Current Ratio (MRQ)Greater than10.303
Debt to Asset Ratio (MRQ)Less than14.249
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.976
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Biora Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5017.054
Ma 20Greater thanMa 500.220
Ma 50Greater thanMa 1000.220
Ma 100Greater thanMa 2000.665
OpenGreater thanClose0.220
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Biora Therapeutics Inc

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On December 27, 2024, Biora Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Fundamental data was last updated by Penke on 2025-03-26 19:16:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biora Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -3,102,875.0% means that $-31,028.75 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biora Therapeutics Inc:

  • The MRQ is -3,102,875.0%. The company is making a huge loss. -2
  • The TTM is -3,102,875.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,102,875.0%TTM-3,102,875.0%0.0%
TTM-3,102,875.0%YOY-16,009.8%-3,086,865.2%
TTM-3,102,875.0%5Y-626,712.6%-2,476,162.4%
5Y-626,712.6%10Y-522,277.3%-104,435.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,102,875.0%-109.6%-3,102,765.4%
TTM-3,102,875.0%-187.7%-3,102,687.3%
YOY-16,009.8%-206.2%-15,803.6%
5Y-626,712.6%-404.0%-626,308.6%
10Y-522,277.3%-526.8%-521,750.5%
4.3.1.2. Return on Assets

Shows how efficient Biora Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • -397.6% Return on Assets means that Biora Therapeutics Inc generated $-3.98 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biora Therapeutics Inc:

  • The MRQ is -397.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -397.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-397.6%TTM-397.6%0.0%
TTM-397.6%YOY-91.2%-306.4%
TTM-397.6%5Y-184.6%-213.0%
5Y-184.6%10Y-172.3%-12.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-397.6%-14.4%-383.2%
TTM-397.6%-14.8%-382.8%
YOY-91.2%-14.6%-76.6%
5Y-184.6%-15.6%-169.0%
10Y-172.3%-18.0%-154.3%
4.3.1.3. Return on Equity

Shows how efficient Biora Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Biora Therapeutics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biora Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--17.7%+17.7%
TTM--18.3%+18.3%
YOY--19.2%+19.2%
5Y--24.3%+24.3%
10Y--26.3%+26.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biora Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biora Therapeutics Inc is operating .

  • Measures how much profit Biora Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of -2,865,225.0% means the company generated $-28,652.25  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biora Therapeutics Inc:

  • The MRQ is -2,865,225.0%. The company is operating very inefficient. -2
  • The TTM is -2,865,225.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,865,225.0%TTM-2,865,225.0%0.0%
TTM-2,865,225.0%YOY-12,544.3%-2,852,680.7%
TTM-2,865,225.0%5Y-578,288.3%-2,286,936.7%
5Y-578,288.3%10Y-481,921.9%-96,366.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,865,225.0%-224.0%-2,865,001.0%
TTM-2,865,225.0%-281.8%-2,864,943.2%
YOY-12,544.3%-227.6%-12,316.7%
5Y-578,288.3%-398.6%-577,889.7%
10Y-481,921.9%-512.4%-481,409.5%
4.3.2.2. Operating Ratio

Measures how efficient Biora Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 16,925.50 means that the operating costs are $16,925.50 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 16,925.500. The company is inefficient in keeping operating costs low. -1
  • The TTM is 16,925.500. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ16,925.500TTM16,925.5000.000
TTM16,925.500YOY206.534+16,718.966
TTM16,925.5005Y3,446.857+13,478.643
5Y3,446.85710Y2,872.696+574.161
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16,925.5002.323+16,923.177
TTM16,925.5003.192+16,922.308
YOY206.5343.069+203.465
5Y3,446.8575.143+3,441.714
10Y2,872.6967.010+2,865.686
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biora Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biora Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.30 means the company has $0.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 0.303. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.303. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.303TTM0.3030.000
TTM0.303YOY1.636-1.333
TTM0.3035Y1.204-0.901
5Y1.20410Y1.193+0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3033.741-3.438
TTM0.3033.895-3.592
YOY1.6364.507-2.871
5Y1.2045.739-4.535
10Y1.1936.099-4.906
4.4.3.2. Quick Ratio

Measures if Biora Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.25 means the company can pay off $0.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.2550.000
TTM0.255YOY1.344-1.089
TTM0.2555Y0.992-0.737
5Y0.99210Y1.035-0.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2553.086-2.831
TTM0.2553.326-3.071
YOY1.3444.362-3.018
5Y0.9925.726-4.734
10Y1.0356.427-5.392
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biora Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biora Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biora Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 4.25 means that Biora Therapeutics Inc assets are financed with 424.9% credit (debt) and the remaining percentage (100% - 424.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 4.249. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 4.249. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.249TTM4.2490.000
TTM4.249YOY2.911+1.338
TTM4.2495Y2.492+1.757
5Y2.49210Y2.296+0.196
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2490.340+3.909
TTM4.2490.340+3.909
YOY2.9110.314+2.597
5Y2.4920.365+2.127
10Y2.2960.392+1.904
4.5.4.2. Debt to Equity Ratio

Measures if Biora Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.399-0.399
TTM-0.407-0.407
YOY-0.384-0.384
5Y-0.426-0.426
10Y-0.460-0.460
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biora Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -0.17 means the investor is paying $-0.17 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biora Therapeutics Inc:

  • The EOD is -0.028. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.172. Based on the earnings, the company is expensive. -2
  • The TTM is -0.172. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.028MRQ-0.172+0.144
MRQ-0.172TTM-0.1720.000
TTM-0.172YOY-0.021-0.151
TTM-0.1725Y-0.071-0.101
5Y-0.07110Y-0.059-0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.028-1.906+1.878
MRQ-0.172-2.688+2.516
TTM-0.172-3.245+3.073
YOY-0.021-3.240+3.219
5Y-0.071-6.333+6.262
10Y-0.059-7.137+7.078
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biora Therapeutics Inc:

  • The EOD is -0.071. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.438. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.438. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.071MRQ-0.438+0.367
MRQ-0.438TTM-0.4380.000
TTM-0.438YOY-0.015-0.423
TTM-0.4385Y-0.130-0.308
5Y-0.13010Y-0.108-0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.071-2.455+2.384
MRQ-0.438-3.724+3.286
TTM-0.438-4.254+3.816
YOY-0.015-4.356+4.341
5Y-0.130-8.511+8.381
10Y-0.108-9.739+9.631
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biora Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.21 means the investor is paying $-0.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biora Therapeutics Inc:

  • The EOD is -0.034. Based on the equity, the company is expensive. -2
  • The MRQ is -0.210. Based on the equity, the company is expensive. -2
  • The TTM is -0.210. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.034MRQ-0.210+0.176
MRQ-0.210TTM-0.2100.000
TTM-0.210YOY-0.010-0.200
TTM-0.2105Y-0.111-0.099
5Y-0.11110Y-0.093-0.019
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0341.726-1.760
MRQ-0.2102.254-2.464
TTM-0.2102.433-2.643
YOY-0.0102.441-2.451
5Y-0.1113.776-3.887
10Y-0.0934.200-4.293
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biora Therapeutics Inc.

4.8.1. Institutions holding Biora Therapeutics Inc

Institutions are holding 36.002% of the shares of Biora Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Athyrium Capital Management LP24.166421.5081092976200
2024-06-30Vanguard Group Inc1.5418069733012130021.0579
2024-06-30Geode Capital Management, LLC0.41570188027-11218-5.6303
2024-06-30Morgan Stanley - Brokerage Accounts0.27060122386106042648.813
2024-06-30Northern Trust Corp0.1516068572-44-0.0641
2024-06-30TWO SIGMA SECURITIES, LLC0.14650.000566276662760
2024-06-30BlackRock Inc0.143806505100
2024-06-30State Street Corp0.1140515731850055.9369
2024-06-30LPL Financial Corp0.0458020710-400-1.8948
2024-06-30XTX Topco Ltd0.03730.00116885168850
2024-06-30Barclays PLC0.01280579700
2024-06-30Wells Fargo & Co0.00904086-7700-65.3317
2024-09-30Efficient Wealth Management LLC0.00330150015000
2024-06-30TD Waterhouse Canada Inc0.00250112000
2024-06-30Advisor Group Holdings, Inc.0.0014064700
2024-06-30Riggs Asset Management Co Inc0.00090.000140000
2024-06-30Bank of America Corp0.000401791790
2024-06-30Royal Bank of Canada0.0002074-4-5.1282
2024-06-30Steward Partners Investment Advisory, LLC0.000103200
2024-06-30TUCKER ASSET MANAGEMENT LLC00200
Total 27.064121.509612240409+311316+2.5%

4.9.2. Funds holding Biora Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Northern Trust Extended Eq Market Idx0.07010.00023171200
2024-11-30Fidelity Extended Market Index0.182108237-54-0.6513
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01080.0002489480.1637
2024-11-30Fidelity Total Market Index0.07710348700
2024-11-30Fidelity Nasdaq Composite Index0.03810172400
2024-11-30Fidelity Series Total Market Index0.03110140800
2024-06-30SSgA U.S. Total Market Index Strategy0.002089226542.2648
2024-11-30Spartan Total Market Index Pool E0.014063500
2024-09-30Northern Trust Wilshire 50000.0011048000
2024-11-30Spartan Extended Market Index Pool E0.002801285472.973
2024-11-30Fidelity U.S. Equity Index Ins Trust0.00020800
Total 0.42940.000453605+273+0.5%

5.3. Insider Transactions

Insiders are holding 0.103% of the shares of Biora Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-07-05Surbhi SarnaSELL13812.5
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Tax Provision  -706-36,826-37,53237,413-119-301-420684264



5.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets31,215
Total Liabilities132,636
Total Stockholder Equity-101,421
 As reported
Total Liabilities 132,636
Total Stockholder Equity+ -101,421
Total Assets = 31,215

Assets

Total Assets31,215
Total Current Assets19,071
Long-term Assets12,144
Total Current Assets
Cash And Cash Equivalents 15,211
Net Receivables 830
Other Current Assets 3,030
Total Current Assets  (as reported)19,071
Total Current Assets  (calculated)19,071
+/-0
Long-term Assets
Property Plant Equipment 2,770
Goodwill 6,072
Long Term Investments 3,000
Long-term Assets Other 302
Long-term Assets  (as reported)12,144
Long-term Assets  (calculated)12,144
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities62,972
Long-term Liabilities69,664
Total Stockholder Equity-101,421
Total Current Liabilities
Short-term Debt 2,872
Short Long Term Debt 1,976
Accounts payable 2,843
Other Current Liabilities 56,715
Total Current Liabilities  (as reported)62,972
Total Current Liabilities  (calculated)64,406
+/- 1,434
Long-term Liabilities
Long term Debt 43,736
Capital Lease Obligations 1,714
Long-term Liabilities Other 2,211
Long-term Liabilities  (as reported)69,664
Long-term Liabilities  (calculated)47,661
+/- 22,003
Total Stockholder Equity
Common Stock25
Retained Earnings -950,958
Other Stockholders Equity 849,512
Total Stockholder Equity (as reported)-101,421
Total Stockholder Equity (calculated)-101,421
+/-0
Other
Capital Stock25
Cash and Short Term Investments 15,211
Common Stock Shares Outstanding 15,773
Current Deferred Revenue542
Liabilities and Stockholders Equity 31,215
Net Debt 32,215
Net Invested Capital -55,709
Net Working Capital -43,901
Property Plant and Equipment Gross 4,877
Short Long Term Debt Total 47,426



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
116,397
101,727
154,440
108,839
53,525
31,215
31,21553,525108,839154,440101,727116,397
   > Total Current Assets 
88,946
74,648
126,338
98,429
38,116
19,071
19,07138,11698,429126,33874,64888,946
       Cash And Cash Equivalents 
49,005
33,042
92,076
88,397
30,486
15,211
15,21130,48688,39792,07633,04249,005
       Short-term Investments 
20,200
0
0
0
0
0
0000020,200
       Net Receivables 
8,146
22,823
6,634
653
828
830
8308286536,63422,8238,146
       Inventory 
7,616
10,937
12,219
2,147
2,603
0
02,6032,14712,21910,9377,616
       Other Current Assets 
604
1,370
15,409
9,379
6,802
3,030
3,0306,8029,37915,4091,370604
   > Long-term Assets 
27,451
27,079
28,102
10,410
15,409
12,144
12,14415,40910,41028,10227,07927,451
       Property Plant Equipment 
15,339
15,891
17,842
4,012
3,136
2,770
2,7703,1364,01217,84215,89115,339
       Goodwill 
6,219
6,219
6,219
6,072
6,072
6,072
6,0726,0726,0726,2196,2196,219
       Long Term Investments 
0
0
0
0
6,000
3,000
3,0006,0000000
       Intangible Assets 
5,699
4,771
3,843
0
0
0
0003,8434,7715,699
       Other Assets 
194
198
13,924
326
0
0
0032613,924198194
> Total Liabilities 
153,365
185,601
261,434
193,815
155,812
132,636
132,636155,812193,815261,434185,601153,365
   > Total Current Liabilities 
78,057
100,337
72,670
61,609
23,305
62,972
62,97223,30561,60972,670100,33778,057
       Short-term Debt 
1,229
968
338
24
893
2,872
2,872893243389681,229
       Short Long Term Debt 
231
241
271
12
0
1,976
1,976012271241231
       Accounts payable 
11,035
15,754
17,379
8,709
3,606
2,843
2,8433,6068,70917,37915,75411,035
       Other Current Liabilities 
4,774
6,044
54,575
52,575
18,759
56,715
56,71518,75952,57554,5756,0444,774
   > Long-term Liabilities 
75,308
85,264
188,764
132,206
132,507
69,664
69,664132,507132,206188,76485,26475,308
       Long term Debt 
70,615
72,047
161,681
126,392
127,811
43,736
43,736127,811126,392161,68172,04770,615
       Capital Lease Obligations Min Short Term Debt
662
117
20
-12
601
-1,158
-1,158601-1220117662
       Other Liabilities 
3,800
12,859
28,561
5,814
0
0
005,81428,56112,8593,800
       Long-term Liabilities Other 
800
654
1,614
5,622
4,095
2,211
2,2114,0955,6221,614654800
> Total Stockholder Equity
-36,968
-83,874
-106,994
-84,976
-102,287
-101,421
-101,421-102,287-84,976-106,994-83,874-36,968
   Common Stock
8
38
59
146
8
25
25814659388
   Retained Earnings -950,958-826,843-788,686-541,274-348,478-142,469
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
105,473
264,566
434,221
703,564
724,548
849,512
849,512724,548703,564434,221264,566105,473



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue4
Cost of Revenue-555
Gross Profit4-551
 
Operating Income (+$)
Gross Profit4
Operating Expense-67,147
Operating Income-67,143-67,143
 
Operating Expense (+$)
Research Development29,838
Selling General Administrative38,106
Selling And Marketing Expenses0
Operating Expense67,14767,944
 
Net Interest Income (+$)
Interest Income0
Interest Expense-9,815
Other Finance Cost-845
Net Interest Income-10,660
 
Pretax Income (+$)
Operating Income-67,143
Net Interest Income-10,660
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-124,424-9,862
EBIT - interestExpense = -124,424
-124,205
-114,300
Interest Expense9,815
Earnings Before Interest and Taxes (EBIT)-114,609-114,609
Earnings Before Interest and Taxes (EBITDA)-114,054
 
After tax Income (+$)
Income Before Tax-124,424
Tax Provision-264
Net Income From Continuing Ops-122,171-124,688
Net Income-124,115
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses67,147
Total Other Income/Expenses Net-57,28110,660
 

Technical Analysis of Biora Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biora Therapeutics Inc. The general trend of Biora Therapeutics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biora Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biora Therapeutics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biora Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.22 < 0.22 < 0.22.

The bearish price targets are: 0.22 > 0.22 > 0.22.

Know someone who trades $BIOR? Share this with them.πŸ‘‡

Biora Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biora Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biora Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biora Therapeutics Inc. The current macd is -0.00679482.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biora Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biora Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biora Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biora Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiora Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biora Therapeutics Inc. The current adx is 20.77.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biora Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Biora Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biora Therapeutics Inc. The current sar is 0.27813315.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biora Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biora Therapeutics Inc. The current rsi is 17.05. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Biora Therapeutics Inc Daily Relative Strength Index (RSI) ChartBiora Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biora Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biora Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biora Therapeutics Inc Daily Stochastic Oscillator ChartBiora Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biora Therapeutics Inc. The current cci is -66.66666667.

Biora Therapeutics Inc Daily Commodity Channel Index (CCI) ChartBiora Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biora Therapeutics Inc. The current cmo is -75.70580945.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biora Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartBiora Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biora Therapeutics Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Biora Therapeutics Inc Daily Williams %R ChartBiora Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biora Therapeutics Inc.

Biora Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biora Therapeutics Inc. The current atr is 0.00387246.

Biora Therapeutics Inc Daily Average True Range (ATR) ChartBiora Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biora Therapeutics Inc. The current obv is -3,075,613.

Biora Therapeutics Inc Daily On-Balance Volume (OBV) ChartBiora Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biora Therapeutics Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Biora Therapeutics Inc Daily Money Flow Index (MFI) ChartBiora Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biora Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Biora Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biora Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5017.054
Ma 20Greater thanMa 500.220
Ma 50Greater thanMa 1000.220
Ma 100Greater thanMa 2000.665
OpenGreater thanClose0.220
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biora Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Biora Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biora Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biora Therapeutics Inc

I send you an email if I find something interesting about Biora Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biora Therapeutics Inc.

Receive notifications about Biora Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.